Has Medical Affairs Truly Achieved a Position as the Third Strategic Pillar?
Charlotte Kremer (former Astellas) speaks with Danie du Plessis (Kyowa Kirin) and Bjorn Oddens (Merck) about whether Medical Affairs is truly the third strategic pillar.
An Insights-Driven Approach to Creating and Refining the Integrated Medical Communication Strategy and Plan
In this white paper, MedComms, Field Medical and Insights Focus Area Working Groups (FAWGs) demonstrate the value of and elucidate best practices for an insights-driven collaborative approach to creating an iMC S/P.
Empowering Customer Engagement with Artificial Intelligence
The real value of AI is reaped when complex data is transformed into clear, easy-to-understand recommendations that are surfaced at the point of execution.
How Can Real-World Evidence Help Medical Affairs Professionals?
This white paper provides Medical Affairs professionals with the background and history of Real-World Evidence, and its applications in the biopharma industry to benefit patients.
Modern Insights Management: Q&A with Lance Hill, CEO of Within3
MAPS speaks with Lance Hill about the opportunity for Medical Affairs organizations to modernize their operations in the pre-launch and launch phase by harnessing insights management technology.
Leadership Perspectives – Leadership in Medical Safety & Pharmacovigilance
How do leaders make their way to Medical Safety & Pharmacovigilance? The routes are diverse but one constant remains true: They are extremely committed to being an independent voice that amplifies their organization’s commitment to Patient Centricity.
How Digital Thinking Enables Medical Affairs Strategy
Digitalization offers Medical Affairs teams the opportunity to rethink strategy and actions across the lifecycle of traditional and nontraditional products.
Leadership Perspectives – Developing a Cross-Sector Career
In this final article in the Leadership Perspectives series, John Pracyk interviews J&J leaders to explore a bold vision of career development that entails moving across sectors; namely, crossing over between Pharmaceuticals, Medical Devices, Vision, and Consumer Health.
Leadership Perspectives – Preparing the Next Generation of Chief Medical Officers
In conversation with John Pracyk, MD, PhD, MBA, Medical Affairs leaders from Johnson & Johnson describe best practices to prepare our next generation of Chief Medical Officers.
Real World Evidence Applications and How it Can Change Medicine and Biopharma
This podcast focuses on applications of Real World Evidence including FDA criteria for accepting RWE, types of data, RWE study designs and the Totality of Evidence approach.